7240
A.S. Vieira et al. / Tetrahedron 64 (2008) 7234–7241
m/z: 307 (MꢀTBAþ); IR (CHCl3 solution, cmꢀ1): 2945, 2926, 1423,
cmꢀ1): 3020, 2933, 1759, 1725, 1457. GC/MS m/z (%): 409 (1) [Mþ],
318 (15), 290 (35), 119 (12), 106 (21), 91 (100), 43 (78). HRMS (ESI,
positive) m/z calcd for C19H23NO5S2: 410.1096 ([MþH]þ); found:
410.1141 ([MþH]þ). Minor isomer: anti 5b: 1H NMR (300 MHz,
1059, 949.
4.3.11. Tetra-n-butylammonium (1,3-dithian-2-yl)-2-
(4-chloro-phenyl) trifluoroborate (3k)
CDCl3)
d
7.32–7.54 (m, 5H), 5.58 (d, J¼8.2 Hz, 1H), 5.32 (dd, J¼8.2,
Mp¼127 ꢁC; 1H NMR (300 MHz, CDCl3)
d
7.97 (d, J¼8.5 Hz, 2H),
8.2 Hz, 1H), 5.05 (d, J¼15.0 Hz, 1H), 4.55 (dd, J¼8.2, 4.1 Hz, 1H), 4.35
7.18 (d, J¼8.5 Hz, 2H), 3.07 (t, J¼8.0 Hz, 8H), 2.62–2.70 (m, 2H), 2.34
(dt, J¼13.6, 3.5 Hz, 2H), 1.75–2.02 (m, 2H), 1.48–1.56 (m, 8H), 1.34–
1.44 (m, 8H), 0.97 (t, J¼8.0 Hz, 12H); 13C NMR (75 MHz, CDCl3)
(d, J¼15.0 Hz, 1H), 4.27 (d, J¼4.1 Hz, 1H), 2.73–3.12 (m, 2H), 2.56–
2.69 (m, 2H), 1.85–1.98 (m, 2H); 13C NMR (75 MHz, CDCl3)
d 169.8,
168.3, 166.9, 134.6, 128.6, 128.5, 128.3, 75.3, 73.5, 64.1, 54.2, 43.5,
31.4, 29.6, 27.0, 20.5, 20.3.
d
145.4, 131.4 (2C), 127.9, 126.7 (2C), 58.4 (4C), 26.0, 25.8, 24.8 (2C),
23.8 (4C), 19.5 (4C), 13.5 (4C); 19F NMR (282 MHz, CDCl3)
d
ꢀ155.70
(q, J¼61.5 Hz); 11B NMR (96 MHz, CDCl3)
d
4.02 (q, J¼54.8 Hz). Anal.
4.4.3. (3R,4R)-3,4-Diacetoxy-5-(2-n-butyl-1,3-dithianyl)-1-benzyl-
2-pyrrolidinone (5c)
The product 5c was prepared as described in the general pro-
cedure and was obtained in a 90:10 syn/anti mixture as a colorless
oil in 42% yield (195 mg). Major isomer: syn 5c: 1H NMR (300 MHz,
Calcd for C26H46BF3NClS2: C, 57.83; H, 8.59; N, 2.59. Found: C, 57.54;
H, 8.25; N, 2.41. LRMS m/z: 297 (MꢀTBAþ); IR (CHCl3 solution,
cmꢀ1): 2985, 2923, 1429, 1049, 944.
4.4. General procedure for the synthesis of 5-(2-organo-1,3-
dithianyl)-2-pyrrolidinones (5a–e)
CDCl3)
d
7.29–7.46 (m, 5H), 5.41 (d, J¼5.0 Hz, 1H), 5.33 (dd, J¼5.0,
5.0 Hz, 1H), 5.08 (d, J¼14.5 Hz, 1H), 4.16 (d, J¼14.5 Hz, 1H), 4.06 (d,
J¼5.0 Hz, 1H), 2.88–2.96 (m, 2H), 2.50–2.65 (m, 2H), 2.17 (s, 3H),
2.12 (s, 3H), 1.96 (t, J¼7.1 Hz, 2H), 1.80–1.89 (m, 2H), 1.29–1.38 (m,
4.4.1. (3R,4R)-3,4-Diacetoxy-5-(2-methyl-1,3-dithianyl)-1-benzyl-
2-pyrrolidinone (5a)
4H), 0.91 (t, J¼7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3)
d 170.7, 170.3,
To a solution of the 5-acetoxy-2-pyrrolidinone 4 (349 mg,
1.0 mmol) in CH2Cl2 (4.0 mL) at ꢀ78 ꢁC under nitrogen atmosphere
was added dropwise the BF3$Et2O (0.50 mL, 4.0 mmol, 4.0 equiv).
The reaction mixture was kept 1 h at ꢀ78 ꢁC when potassium (2-
methyl-1,3-dithianyl) trifluoroborate (2a) (288 mg, 1.2 mmol,
1.2 equiv) was added in one portion. After 1 h at ꢀ78 ꢁC, the re-
action mixture was stirred 6 h at room temperature when it was
quenched with saturated NaHCO3 (10 mL). The mixture was diluted
with CH2Cl2 (20 mL), and the organic phase was washed with 10%
HCl (10 mL), saturated NaHCO3 (10 mL), and dried over MgSO4.
Evaporation under reduced pressure, followed by column chro-
matography on silica gel (20% ethyl acetate in hexanes) afforded 5a
in an 80:20 syn/anti mixture as a yellow oil, in 68% yield (287 mg).
Both isomers have nearly the same Rf values and they could not be
separated by column chromatography. The syn/anti ratio was de-
termined to be 80:20 by the 1H NMR (300 MHz) analysis of the
crude product. Major isomer: syn 5a: 1H NMR (300 MHz, CDCl3)
168.5,135.2,128.8,128.5,128.3, 75.6, 73.7, 64.7, 54.5, 43.7, 31.5, 29.3,
27.9, 26.6, 24.2, 23.1, 20.8, 20.6, 14.6; IR (CHCl3 solution, cmꢀ1):
3025, 2935, 1751, 1720, 1229. GC/MS m/z (%): 465 (2) [Mþ], 375 (12),
332 (23), 290 (17), 175 (10), 106 (19), 91 (100), 43 (71). HRMS (ESI,
positive) m/z calcd for C23H31NO5S2: 466.1722 ([MþH]þ); found:
466.1751 ([MþH]þ). Minor isomer: anti 5c: 1H NMR (300 MHz,
CDCl3)
d
7.29–7.46 (m, 5H), 5.51 (d, J¼8.2 Hz, 1H), 5.30 (dd, J¼8.2,
8.2 Hz, 1H), 5.03 (d, J¼14.8 Hz, 1H), 4.10 (d, J¼14.8 Hz, 1H), 4.01 (d,
J¼8.2 Hz, 1H), 2.88–2.96 (m, 2H), 2.50–2.65 (m, 2H), 2.16 (s, 3H),
2.10 (s, 3H), 1.96 (t, J¼7.1 Hz, 2H), 1.80–1.89 (m, 2H), 1.29–1.38 (m,
4H), 0.91 (t, J¼7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3)
d 170.5, 170.1,
168.4, 135.1, 128.8, 128.5, 128.3, 75.3, 73.5, 64.4, 54.2, 43.5, 31.4,
29.3, 27.9, 26.6, 24.2, 23.1, 20.8, 20.6, 14.6.
4.4.4. (3R,4R)-3,4-Diacetoxy-5-(2-trimethylsilyl-1,3-dithianyl)-
1-benzyl-2-pyrrolidinone (5d)
The product 5d was prepared as described in the general pro-
cedure and was obtained in a 70:30 syn/anti mixture as a colorless
oil in 63% yield (303 mg). Major isomer: syn 5d: 1H NMR (300 MHz,
d
7.27–7.34 (m, 5H), 5.39 (d, J¼4.8 Hz, 1H), 5.35 (dd, J¼4.8, 4.8 Hz,
1H), 5.11 (d, J¼15.0 Hz,1H), 4.20 (d, J¼15.0 Hz,1H), 4.15 (d, J¼4.8 Hz,
1H), 2.87–2.95 (m, 2H), 2.52–2.69 (m, 2H), 2.16 (s, 3H), 2.05 (s, 3H),
CDCl3)
d
7.26–7.35 (m, 5H), 5.38 (d, J¼4.7 Hz, 1H), 5.34 (dd, J¼4.7,
1.95 (s, 3H), 1.82–1.91 (m, 2H); 13C NMR (75 MHz, CDCl3)
d
170.4,
4.7 Hz, 1H), 5.10 (d, J¼15.2 Hz, 1H), 4.18 (d, J¼15.2 Hz, 1H), 4.14 (d,
J¼4.7 Hz, 1H), 2.88–2.97 (m, 2H), 2.53–2.70 (m, 2H), 2.15 (s, 3H),
2.07 (s, 3H), 1.83–1.93 (m, 2H), 0.13 (s, 9H); 13C NMR (75 MHz,
169.9, 167.0, 134.9, 128.9, 128.4, 128.2, 75.5, 73.8, 64.8, 54.6, 43.9,
31.6, 29.2, 27.8, 24.2, 20.8, 20.6; IR (CHCl3 solution, cmꢀ1): 3021,
2937, 1755, 1721, 1451. GC/MS m/z (%): 423 (2) [Mþ], 309 (10), 290
(24), 230 (28), 188 (63), 160 (13), 133 (17), 106 (15), 91 (100), 65 (11),
43 (45). HRMS (ESI, positive) m/z calcd for C20H25NO5S2: 424.1253
([MþH]þ); found: 424.1241 ([MþH]þ). Minor isomer: anti 5a: 1H
CDCl3) d 170.0, 169.5, 167.3, 134.7, 128.6, 128.5, 128.1, 75.1, 73.3, 62.6,
51.8, 43.7, 31.5, 29.3, 27.5, 20.9, 20.5, 1.3; IR (CHCl3 solution, cmꢀ1):
3021, 2937, 1750, 1724. GC/MS m/z (%): 481 (1) [Mþ], 390 (21), 347
(15), 290 (24), 106 (13), 91 (100), 43 (75). HRMS (ESI, positive) m/z
calcd for C22H31NO5S2Si: 482.1491 ([MþH]þ); found: 482.1536
NMR (300 MHz, CDCl3)
d
7.27–7.34 (m, 5H), 5.56 (d, J¼8.0 Hz, 1H),
5.30 (dd, J¼8.0, 8.0 Hz, 1H), 5.08 (d, J¼15.0 Hz, 1H), 4.72 (d,
J¼8.0 Hz, 1H), 4.05 (d, J¼15.0 Hz, 1H), 2.87–2.95 (m, 2H), 2.52–2.69
([MþH]þ). Minor isomer: anti 5d: 1H NMR (300 MHz, CDCl3)
d 7.26–
7.35 (m, 5H), 5.55 (d, J¼8.3 Hz, 1H), 5.29 (dd, J¼8.3, 8.3 Hz, 1H), 5.07
(d, J¼14.7 Hz, 1H), 4.14 (d, J¼14.7 Hz, 1H), 4.03 (d, J¼8.3 Hz, 1H),
2.86–2.93 (m, 2H), 2.51–2.68 (m, 2H), 2.14 (s, 3H), 2.06 (s, 3H), 1.83–
(m, 2H), 2.18 (s, 3H), 2.14 (s, 3H), 1.94 (s, 3H), 1.82–1.91 (m, 2H); 13
C
NMR (75 MHz, CDCl3) d 170.2,169.7, 165.8, 134.4, 128.8, 128.3, 128.0,
75.4, 72.7, 64.0, 53.8, 43.7, 31.4, 29.0, 27.6, 24.0, 20.7, 20.5.
1.93 (m, 2H), 0.12 (s, 9H); 13C NMR (75 MHz, CDCl3)
d 170.1, 169.4,
167.2, 134.6, 128.6,128.5,128.0, 74.8, 73.2, 62.5, 51.6, 43.6, 31.4, 29.3,
27.5, 20.8, 20.4, 1.3.
4.4.2. (3R,4R)-3,4-Diacetoxy-5-(1,3-dithianyl)-1-benzyl-2-
pyrrolidinone (5b)
The product 5b was prepared as described in the general pro-
cedure and was obtained in a 70:30 syn/anti mixture as a colorless
oil in 54% yield (220 mg). Major isomer: syn 5b: 1H NMR (300 MHz,
4.4.5. (3R,4R)-3,4-Diacetoxy-5-(2-allyl-1,3-dithianyl)-1-benzyl-
2-pyrrolidinone (5e)
The product 5e was prepared as described in the general pro-
cedure and was obtained in a 90:10 syn/anti mixture as a colorless
oil in 51% yield (229 mg). Major isomer: syn 5e: 1H NMR (300 MHz,
CDCl3)
d
7.32–7.54 (m, 5H), 5.42 (d, J¼4.9 Hz, 1H), 5.38 (dd, J¼4.9,
4.9 Hz, 1H), 5.14 (d, J¼15.0 Hz, 1H), 4.52 (dd, J¼4.9, 4.3 Hz, 1H), 4.32
(d, J¼15.0 Hz, 1H), 4.23 (d, J¼4.3 Hz, 1H), 2.73–3.12 (m, 2H), 2.56–
2.69 (m, 2H), 2.19 (s, 3H), 2.10 (s, 3H), 1.85–1.98 (m, 2H); 13C NMR
CDCl3)
d
7.28–7.35 (m, 5H), 5.73–5.91 (m, 1H), 5.40 (d, J¼4.9 Hz,1H),
5.30 (dd, J¼17.3, 1.5 Hz, 1H), 5.26 (dd, J¼4.9, 4.9 Hz, 1H), 5.22 (dd,
J¼10.0, 1.5 Hz), 5.10 (d, J¼15.1 Hz, 1H), 4.23 (d, J¼15.1 Hz, 1H),
4.12 (d, J¼4.9 Hz, 1H), 2.87–2.95 (m, 2H), 2.75 (d, J¼5.7 Hz, 2H),
(75 MHz, CDCl3)
d 170.1, 168.5, 167.1, 134.7, 128.7, 128.5, 128.2, 75.4,
73.6, 64.3, 54.3, 43.7, 31.7, 29.7, 27.1, 20.6, 20.4; IR (CHCl3 solution,